Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis

This study has been terminated.
(Low enrollment)
The Egyptian Company for Blood Transfusion Services
Tanta Fever Hospital
Banha Fever Hospital
Alexandria University
Information provided by (Responsible Party):
Samer S. El-Kamary, University of Maryland Identifier:
First received: September 17, 2008
Last updated: June 7, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2015
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)